These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 651659)

  • 21. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjects.
    Heynen G; Cornet F; Franchimont P; Gaspar S; Plomteux G; Cession-Fossion G; Russel RG; Kanis JA
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):619-24. PubMed ID: 6975547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.
    Somerville PJ; Kaye M
    Kidney Int; 1978 Sep; 14(3):245-54. PubMed ID: 723151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal absorption of calcium: role of dietary phosphate and vitamin D.
    Brautbar N; Levine BS; Walling MW; Coburn JW
    Am J Physiol; 1981 Jul; 241(1):G49-53. PubMed ID: 6264809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
    Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
    Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL
    J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L; Egfjord M; Olgaard K
    Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
    Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hydrochlorothiazide on 1,25-dihydroxyvitamin D3-induced changes in calcium metabolism in experimental hypoparathyroidism in rats.
    Rizzoli R; Hugi K; Fleisch H; Bonjour JP
    Clin Sci (Lond); 1981 Jan; 60(1):101-7. PubMed ID: 6894567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
    Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
    Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia.
    Olgaard K; Finco D; Schwartz J; Arbelaez M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
    Kidney Int; 1984 Dec; 26(6):791-7. PubMed ID: 6335904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status.
    Llach F; Coburn JW; Brickman AS; Kurokawa K; Norman AW; Canterbury JM; Reiss E
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1054-60. PubMed ID: 194908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
    Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
    Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of vitamin D and diet magnesium on magnesium metabolism.
    Levine BS; Brautbar N; Walling MW; Lee DB; Coburn JW
    Am J Physiol; 1980 Dec; 239(6):E515-23. PubMed ID: 6255806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of vitamin D3 and 1,25-dihydroxyvitamin D3 on intestinal transport of phosphate.
    Peterlik M; Wasserman RH
    Adv Exp Med Biol; 1977; 81():323-32. PubMed ID: 197821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of vitamin D: current status.
    DeLuca HF
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early and direct effect of 1,25-dihydroxycholecalciferol on calcium uptake by duodena of rachitic chicks.
    Fullmer CS; Brindak ME; Edelstein S; Wasserman RH
    Proc Soc Exp Biol Med; 1984 Dec; 177(3):455-8. PubMed ID: 6334856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 1alpha-hydroxycholecalciferol, 1,25-dihydroxycholecalciferol, 3 deoxy-1alpha-hydroxycholecalciferol, 24R, 25-dihydroxycholecalciferol and successful renal transplantation on calcium absorption in haemodialysis patients.
    Pierides AM; Aljama P; Kerr DN; Scott M; Norman AW
    Nephron; 1978; 20(4):203-11. PubMed ID: 345140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
    Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
    Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.